 |
|
|
| |
Utilization Patterns and HIV Incidence Within the First Year of Initiation of TDF/FTC for HIV Pre-exposure Prophylaxis (PrEP) Among Insured Individuals in the US
|
| |
| |
HIVR4P 2021 (Virtual event); 27-28 January & 3-4 February 2021
Reported by Jules Levin
Yohance Whiteside1; Tania Gulati2; Marco Mesa-frias1; Niranjan Kathe2; Kirti Mirchandani2; Riddhi Markan2; Akanksha Singh2
1Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA; 2Complete Health Economics and Outcomes Research Solutions, North Wales, PA, USA
|
| |
|
|
|
|
|
